187 related articles for article (PubMed ID: 38002305)
1. Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase.
He X; Schuchman EH
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002305
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of sphingolipid metabolism in Alzheimer's disease.
He X; Huang Y; Li B; Gong CX; Schuchman EH
Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
[TBL] [Abstract][Full Text] [Related]
3. Acid Sphingomyelinase Deficiency Ameliorates Farber Disease.
Beckmann N; Becker KA; Kadow S; Schumacher F; Kramer M; Kühn C; Schulz-Schaeffer WJ; Edwards MJ; Kleuser B; Gulbins E; Carpinteiro A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835809
[TBL] [Abstract][Full Text] [Related]
4. The reverse activity of human acid ceramidase.
Okino N; He X; Gatt S; Sandhoff K; Ito M; Schuchman EH
J Biol Chem; 2003 Aug; 278(32):29948-53. PubMed ID: 12764132
[TBL] [Abstract][Full Text] [Related]
5. The molecular medicine of acid ceramidase.
Frohbergh M; He X; Schuchman EH
Biol Chem; 2015 Jun; 396(6-7):759-65. PubMed ID: 25938220
[TBL] [Abstract][Full Text] [Related]
6. Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase.
Jenkins RW; Clarke CJ; Canals D; Snider AJ; Gault CR; Heffernan-Stroud L; Wu BX; Simbari F; Roddy P; Kitatani K; Obeid LM; Hannun YA
J Biol Chem; 2011 Apr; 286(15):13292-303. PubMed ID: 21335555
[TBL] [Abstract][Full Text] [Related]
7. Development of an acid ceramidase activity-based probe.
Ouairy CM; Ferraz MJ; Boot RG; Baggelaar MP; van der Stelt M; Appelman M; van der Marel GA; Florea BI; Aerts JM; Overkleeft HS
Chem Commun (Camb); 2015 Apr; 51(28):6161-3. PubMed ID: 25748248
[TBL] [Abstract][Full Text] [Related]
8. Liposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluation.
Aldosari MH; de Vries RP; Rodriguez LR; Hesen NA; Beztsinna N; van Kuilenburg ABP; Hollak CEM; Schellekens H; Mastrobattista E
Eur J Pharm Biopharm; 2019 Apr; 137():185-195. PubMed ID: 30818011
[TBL] [Abstract][Full Text] [Related]
9. Preparation of fluorescence-labeled GM1 and sphingomyelin by the reverse hydrolysis reaction of sphingolipid ceramide N-deacylase as substrates for assay of sphingolipid-degrading enzymes and for detection of sphingolipid-binding proteins.
Nakagawa T; Tani M; Kita K; Ito M
J Biochem; 1999 Sep; 126(3):604-11. PubMed ID: 10467178
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
11. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
Lightle SA; Oakley JI; Nikolova-Karakashian MN
Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
[TBL] [Abstract][Full Text] [Related]
12. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content.
Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095
[TBL] [Abstract][Full Text] [Related]
13. In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
Sen NE; Arsovic A; Meierhofer D; Brodesser S; Oberschmidt C; Canet-Pons J; Kaya ZE; Halbach MV; Gispert S; Sandhoff K; Auburger G
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766565
[TBL] [Abstract][Full Text] [Related]
14. Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.
Tani M; Igarashi Y; Ito M
J Biol Chem; 2005 Nov; 280(44):36592-600. PubMed ID: 16126722
[TBL] [Abstract][Full Text] [Related]
15. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.
Hadas Y; Vincek AS; Youssef E; Żak MM; Chepurko E; Sultana N; Sharkar MTK; Guo N; Komargodski R; Kurian AA; Kaur K; Magadum A; Fargnoli A; Katz MG; Hossain N; Kenigsberg E; Dubois NC; Schadt E; Hajjar R; Eliyahu E; Zangi L
Circulation; 2020 Mar; 141(11):916-930. PubMed ID: 31992066
[TBL] [Abstract][Full Text] [Related]
16. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
17. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of recombinant, human acid ceramidase. Catalytic reactions and interactions with acid sphingomyelinase.
He X; Okino N; Dhami R; Dagan A; Gatt S; Schulze H; Sandhoff K; Schuchman EH
J Biol Chem; 2003 Aug; 278(35):32978-86. PubMed ID: 12815059
[TBL] [Abstract][Full Text] [Related]
19. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis].
Serebrov VIu; Kuz'menko DI; Burov PG; Sapugol'tseva OB
Biomed Khim; 2010; 56(2):283-9. PubMed ID: 21341516
[TBL] [Abstract][Full Text] [Related]
20. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
